Related Experiment Video
Updated: Jul 18, 2025
09:58
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
2.8K
Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.
Helong Gong1, Busheng Xue2, Jinlong Ru3
1Department of Orthopaedic Surgery, Shengjing Hospital, China Medical University, No. 36 Sanhao Street, Heping District, Shenyang 110004, China.
Cancers
|August 26, 2023
Summary
Ewing sarcoma (EwS) treatment is challenging due to macrometastases and relapse. This review explores targeting the EWS-FLI1 oncogene complex and its downstream pathways for novel therapeutic options.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing sarcoma (EwS) is a rare pediatric bone and soft tissue cancer.
- Macrometastases and relapse present significant treatment challenges despite improved prognoses.
- The EWS-FLI1 oncogene drives EwS cellular transformation by altering gene expression.
Purpose of the Study:
- To review EWS-FLI1 protein partners and downstream pathways in EwS.
- To discuss therapeutic strategies targeting these pathways for EwS treatment.
Main Methods:
- Literature review of studies on EWS-FLI1.
- Analysis of protein-protein interactions and downstream signaling in EwS.
- Summary of current and emerging targeted therapies.
Main Results:
- EWS-FLI1 directly binds GGAA repeats, impacting RNA splicing and DNA damage response.
- The intrinsically disordered structure of EWS-FLI1 hinders direct pharmacological targeting.
- Targeting EWS-FLI1 complexes and downstream pathways offers viable therapeutic avenues.
Conclusions:
- Understanding EWS-FLI1 interactions is crucial for developing effective EwS treatments.
- Targeted therapies focusing on EWS-FLI1 downstream pathways show promise for managing recurrent or metastatic EwS.
- Further research into EWS-FLI1 biology can lead to improved clinical outcomes for pediatric cancer patients.
Related Concept Videos
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K